ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532296 announcements Glenmark Pha announcements and dividends declared BSE

Glenmark Pha Complete list of announcements declared & dividend announcements by Glenmark Pha 532296

Glenmark Pha 532296 listed on BSE and deals in

Announcements and dividends declared by Glenmark Pha 532296

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
Glenmark Pharmaceuticals has received tentative approval by the United States Food & Drug Administration (USFDA) for Axitinib tablets in the strength of 1 mg and 5 mg, the company said in a regulatory filing.
Announcement as on 01 December 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug
Drug major Glenmark Pharma on Tuesday said it has received tentative approval from the US health regulator for Axitinib tablets, used in the treatment of kidney cancer. The tentatively approved product is the generic version of Inlyta tablets of PF Prism C
Announcement as on 01 December 2020

As refinancing risks ease, S&P affirms Glenmark Pharma's 'BB-' rating
The rating agency has a stable outlook on Glenmark Pharma's rating and also removed it from 'CreditWatch'
Announcement as on 25 November 2020

Buy Glenmark Pharmaceuticals: target of Rs 635: ICICI Direct
ICICI Direct is bullish on Glenmark Pharmaceuticals recommended buy rating on the stock with a target price of Rs 635 in its research report dated November 09, 2020.
Announcement as on 12 November 2020

Glenmark Pharma gets USFDA nod for Tacrolimus capsules
Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus Capsules USP in the strengths of 0.5 mg, 1 mg and 5 mg, Glenmark said in a regulatory filing.
Announcement as on 11 November 2020

Announcements by Glenmark Pha first page | Next page | Prev page |

532296 Glenmark Pha current price & indicator signals

Moving Averages for Glenmark Pha

  • 5Day Average: 2190.73
  • 12Day Average: 2180.05
  • 20Day Average: 2174.3
  • 50Day Average: 2264.73
  • 100Day Average: 2189.1
  • 150Day Average: 2120.84
  • 200Day Average: 2074.12

532296 Indicators & signals

Indicator MACD (12,26,9)

2186.05, 2200.99, -22.93
Indicator MACD is in negative zone

Indicator ADX (14)

1.56, 16.32, 16.83
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532296 Glenmark Pha are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Fri Jul 2026 2209.85 2192.50 to 2244.00 0.68% 1.02 times
02 Thu Jul 2026 2195.00 2146.55 to 2213.90 1.73% 1.29 times
01 Wed Jul 2026 2157.70 2152.40 to 2220.00 -2.14% 0.93 times
30 Tue Jun 2026 2204.90 2184.35 to 2220.05 0.86% 0.76 times
29 Mon Jun 2026 2186.20 2155.65 to 2217.10 1.53% 1.13 times
25 Thu Jun 2026 2153.20 2146.60 to 2193.00 -1.22% 0.22 times
24 Wed Jun 2026 2179.85 2157.85 to 2198.00 -0.04% 0.39 times
23 Tue Jun 2026 2180.65 2166.70 to 2234.05 -0.41% 1.78 times
22 Mon Jun 2026 2189.55 2173.45 to 2215.40 -1.11% 1.13 times
19 Fri Jun 2026 2214.05 2146.60 to 2222.10 2.78% 2.07 times
18 Thu Jun 2026 2154.25 2135.50 to 2160.00 0.89% 0.29 times
17 Wed Jun 2026 2135.35 2109.00 to 2170.00 -0.99% 0.8 times

Videos related to: 532296 announcements Glenmark Pha announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

532296 announcements Glenmark Pha announcements and dividends declared BSE

 

Back to top